Literature DB >> 22264785

Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma.

Lindy E Barrett1, Zvi Granot, Courtney Coker, Antonio Iavarone, Dolores Hambardzumyan, Eric C Holland, Hyung-song Nam, Robert Benezra.   

Abstract

Within high-grade gliomas, the precise identities and functional roles of stem-like cells remain unclear. In the normal neurogenic niche, ID (Inhibitor of DNA-binding) genes maintain self-renewal and multipotency of adult neural stem cells. Using PDGF- and KRAS-driven murine models of gliomagenesis, we show that high Id1 expression (Id1(high)) identifies tumor cells with high self-renewal capacity, while low Id1 expression (Id1(low)) identifies tumor cells with proliferative potential but limited self-renewal capacity. Surprisingly, Id1(low) cells generate tumors more rapidly and with higher penetrance than Id1(high) cells. Further, eliminating tumor cell self-renewal through deletion of Id1 has modest effects on animal survival, while knockdown of Olig2 within Id1(low) cells has a significant survival benefit, underscoring the importance of non-self-renewing lineages in disease progression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264785     DOI: 10.1016/j.ccr.2011.11.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  73 in total

1.  Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.

Authors:  Fanghui Lu; Ying Chen; Chuntao Zhao; Haibo Wang; Danyang He; Lingli Xu; Jincheng Wang; Xuelian He; Yaqi Deng; Ellen E Lu; Xue Liu; Ravinder Verma; Hong Bu; Rachid Drissi; Maryam Fouladi; Anat O Stemmer-Rachamimov; Dennis Burns; Mei Xin; Joshua B Rubin; El Mustapha Bahassi; Peter Canoll; Eric C Holland; Q Richard Lu
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

2.  Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.

Authors:  Pítia F Ledur; Chong Liu; Hua He; Alexandra R Harris; Darlan C Minussi; Hai-Yan Zhou; Mark E Shaffrey; Ashok Asthagiri; Maria Beatriz S Lopes; David Schiff; Yi-Cheng Lu; James W Mandell; Guido Lenz; Hui Zong
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 3.  Cell of origin for malignant gliomas and its implication in therapeutic development.

Authors:  Hui Zong; Luis F Parada; Suzanne J Baker
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

Review 4.  Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

Authors:  Dimphna H Meijer; Michael F Kane; Shwetal Mehta; Hongye Liu; Emily Harrington; Christopher M Taylor; Charles D Stiles; David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

5.  Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.

Authors:  Sabah O Ghazi; Michelle Stark; Zhiguo Zhao; Bret C Mobley; Alex Munden; Laura Hover; Ty William Abel
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

6.  An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells.

Authors:  Dimphna H Meijer; Yu Sun; Tao Liu; Michael F Kane; John A Alberta; Guillaume Adelmant; Robert Kupp; Jarrod A Marto; David H Rowitch; Yoshihiro Nakatani; Charles D Stiles; Shwetal Mehta
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

7.  Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Authors:  Jun Fu; Dimpy Koul; Jun Yao; Shuzhen Wang; Ying Yuan; Howard Colman; Erik P Sulman; Frederick F Lang; W K Alfred Yung
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

8.  Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.

Authors:  Liliana Soroceanu; Ryuichi Murase; Chandani Limbad; Eric Singer; Juanita Allison; Isabel Adrados; Rumi Kawamura; Arash Pakdel; Yayoi Fukuyo; Daniel Nguyen; Sabeena Khan; Robert Arauz; Garret L Yount; Dan H Moore; Pierre-Yves Desprez; Sean D McAllister
Journal:  Cancer Res       Date:  2012-12-13       Impact factor: 12.701

9.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

10.  Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.

Authors:  Felipe de Almeida Sassi; Lílian Caesar; Mariane Jaeger; Carolina Nör; Ana Lucia Abujamra; Gilberto Schwartsmann; Caroline Brunetto de Farias; Algemir Lunardi Brunetto; Patrícia Luciana da Costa Lopez; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2014-01-25       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.